Photodynamic Therapy for the Most Common Skin Cancer Wins Approval
(MedPage Today) -- The FDA approved aminolevulinic acid hydrochloride 10% (Ameluz) in combination with photodynamic therapy for treating adults with superficial basal cell carcinoma, maker Biofrontera announced on Monday. The approval represents...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.